miércoles, 31 de julio de 2013

Today’s articles on Investing Ideas

Alpha-Rich Ideas

Forget The Temporary Worries, Lenovo Built To Continue Winning
by Stephen Simpson, CFA

Editor's notes: Exaggerated PC-related fears and pessimistic views of Lenovo's mobile device opportunity have left shares deeply undervalued. Focus on the middle of the market means the stock has 35-60% upside.

Broadcom: Unloved And Undervalued, Shares Have 30% Near-Term Upside
by Ashraf Eassa

Editor's notes: The recent BRCM earnings sell-off was overdone, says tech expert Ashraf Eassa. With the guidance not likely to hit the company's yearly earnings significantly, shares could retrace quickly.

Stocks Moving From Alpha-Rich Articles

Yesterday, GuruFundPicks said a recent debt financing would allow Oxford Resource Partners (OXF) to continue executing its turnaround plan. The stock finished the day +21.1%. Read article »

On June 28, Colin King wrote about Dolan Company's (DM) growth potential and strong cash generating businesses. The stock is +64% since. Read article »

Breaking Alpha-Rich Articles (for Pro Subscribers. Learn more»)

Ignite Your Portfolio With This Radioactive Pair Trade by Wall Street Advisors

This Coal Company Offers Multi-Bagger Potential Despite Its Problems by GuruFundPicks

A Sweet Dream For Investors by Mike Arnold

This Company: Potential Multi-Bagger Means Little Risk/High Reward by McDuck Capital

Long Ideas

How Spherix Inc. Could Be Valued At $14-$61 Per Share by super-trades

Oaktree Capital: An Alternate Asset Manager To Look At For The Next Crisis by Mike Arnold

MDC Q2 2013 Earnings: The Fallacy Of Following The Headlines by Money Investor

Smith & Wesson Holding: A Good Investment Opportunity by Investor Wand

The Eagle Ford Pure Play by Casey Hoerth

BMW's I3 Electric Car Is No Threat To Tesla's Model S by Kevin Babb

Pitney Bowes Soars After Posting A Solid Quarter by Albert Alfonso

Durata Therapeutics' Novel Antibiotic Makes It A Prime Takeover For 2013 by Bob's Stocks

Walgreen's Mobile Strategy Scores With Retail Customers by Alan Kotok

Why Solazyme Will Impact The Food Industry, Part 2 by Kevin Quon

Biota Pharmaceuticals: Partnership With GlaxoSmithKline Should Excite Investors by Equity Options Guru

Gilead Sciences Hepatitis C Approval May Be Factored In by William Meyers

Galena: Why We Think There Is More Room For Significant Share Price Appreciation by Grant Zeng

Potash And The Fertilizer And Agriculture Companies: Don't Panic Is Rule # 1 by Tim Gallagher

Voltari: A Hidden Story Stock At Venture Capital Valuations by Paulo Santos

Global Geophysical Services: A Compelling Small-Cap Turnaround Story by Brian Grosso

Coal Without The Risk by Paulo Santos

Will Nokia Rebound To Prove The Bears Wrong In Q3 And Q4 Of 2013? by Alex Jordon

Qualcomm Reports Higher Earnings, Optimism About Chip Outlook by Alex Jordon

Take A Trip To The Travelzoo by Nathaniel Matherson

Potash Corp: Playing Today's Massive Sell-Off by Chris Bailey

Citigroup Building A Strong Future; Get In Now by Tom Dorsey

Kennametal: Betting On A Solid Industrial by Being Unordinary

AIG Stock Warrants: The Best Way To Play The Rebound by Quinn Bredl

Great Leadership And Massive Opportunities Makes This Hire Terrific by Brian Nichols

IBM's Cloud Speed Up With BLU Acceleration by StockSaints

Broadcom: This Beaten-Down Tech Stock Is Too Cheap To Ignore by Trade In Mexico

Micron: The Story Isn't Tech ... by Russ Fischer

Michael Baker: The Board Has Created An Excellent Deal For Shareholders by The Value Investor

Gilead Nuc Forecasts At Unprecedented Levels - Where To Set Stock Expectations by Mad Titan

Citigroup's Competitive Advantage by I Know First Research

Sensing A Big Move For InvenSense This Week by Esekla

Cutera Should Win Investor And Customer Beauty Contest by John Leonard

West Fraser Timber Is A Strong Buy With Significant Upside Potential by Deepak Pundir

Everest Re: A Conservatively-Valued Insurance Stock With Price And Earnings Momentum by DoctoRx

Nokia Presents Upside To Those With A Stomach by Redrut

Analysis Of Vical's Allovectin-7: Best Results Ever In A Melanoma Phase 3 Trial by Intrinsic Value Asset Management

KongZhong: Major Growth Potential But Still Speculation Only by The Oxen Group

Amkor: Staying Bullish As Temporary Slowdown Does Not Damage Core Thesis by Ashraf Eassa

AudioCodes: Let Institutional Accumulation Begin by Josh Franklin

Hawaiian Holdings Shares Can Double With Upcoming Catalyst And Low Valuation To Peers by Chris Katje

Pactera: An Undervalued Growth Stock by Bottom Up Investing

Growth Potential, Powerful Moat Make Corporate Executive Board A Must-Have For Your Watch List by Gregory Vousvounis

Renasant Corporation: Organic Growth With An Acquisition Pending, Is This Bank A Buy? by Profit Fan

De-Leveraged Balance Sheet To Drive Dean Foods' Stock Higher by Andy Batts

FelCor Lodging Trust: Transformation Will Unlock Significant Gains by Bret Jensen

United Therapeutics - A Low PE, Fast-Growing Biotech Stock by DoctoRx

The Long Case For Vipshop Holdings by ONeil Trader

Starbucks Looks More Promising Than Ever by Price Point

Does Meredith Offer A Better Home And Garden? by Rochelle Jenks

Strategies Catalyzed By Exxon's Earnings by Quoth the Raven

Nobility Homes: A Hidden Away Builder Of Manufactured Housing With A Large Margin Of Safety by Matthew Dow

United Therapeutics Reports Record Earnings, Guides Higher, And Is Still Cheap by Cory Renauer

Perrigo Company - Elan Deal Brings Advantages At A Fair Price by The Value Investor

Why Biodel Will Have Positive Phase II Results by Sam Quirke

Glu Mobile: Crossing The Chasm With Android Consoles by Mark Gomes

Is Sprint A Strong Buy? Not So Fast by Harmohan Parmar

Major Change Could Accelerate Growth At Move Inc. by Valuable Insights

Celgene Up Over 100% In A Year: Still A Buy? by William Meyers

IGT: The Game Maker To Own by Marshall Hargrave

Black Earth Farming: Own The Fields Of Production by Mike Arnold

African Barrick Gold Is Compelling, But Cheap For A Reason by Ben Kramer-Miller

USAT: Great Penetration Story I Believe Is Ready To Hit Inflection Point by Steven D. Friedman

Inovio May Prove To Be Merck's Solution by D. Mero

BioPharma Catalyst Trade Pick Of The Week: Biodel by StockMatusow

Halliburton Lucky To Get Away Lightly In Oil Spill Disaster by Harlan Kessler

A Tiny Oil & Gas Trust With A Huge Margin Of Safety And A Catalyst by For The Long Haul

Synta's Anti-Cancer Therapy Data Extremely Positive And More Upside Is Likely by Christopher F. Davis

National Oilwell Varco Headed To $102 by Interactive Buyside

Lorillard: E-Cigs Provide Solid Growth Going Forward by Steve Nicastro

Short Ideas

Herbalife: Evidence Of Saturation Supports Short Thesis by Matt Stewart

GreenHunter: Better Short Selling Opportunity Than Trading Against SAC by Josh Young

Sell Great Northern Iron Ore - Shares Overpriced And Dropping Fast by Tom Dorsey

Exact Sciences - Cologuard Is Strike 3, And EXAS Is Out (5 Of 5) by Alpha Exposure

Jones New York: Takeover Premium Unjustified, Look Out Below by Josh Arnold

Hugoton Royalty Trust Is Overvalued By 45% by Black Gold

Why Groupon Might Struggle To Justify Any Further Increase In Its Share Price by George Ronan

3 Simple Bearish Points For LinkedIn Into Earnings by Quoth the Raven

Potash Cartel Shatters Profitability by Redrut

No Country For DryShips by Equity Whisper

Quick Picks & Lists

It Is Time To Take Profits In Fertilizer Stocks by David White

Can Booz Allen Continue Its Bull Run? by MagicDiligence

Memory Markets: Why It 'Is' Different This Time by Electric Phred

5 Significant Short Interest Declines by Bill Maurer

Small-Cap Dividend ETFs Offer Allure Too by Benzinga

How To Invest In The World's No. 1 Oil Producer by Michael Shulman

Time To Make Some Adjustments To The 'Retire Young' Portfolio by Jacob Steinberg

Playing The Fertilizer Sector Roller Coaster by BubbleBustInvesting

Celgene Ups Its Stake In Acetylon With $100 Million Deal by EP Vantage

Under Armour: The Trend Remains Bullish by Carl Cachia

In No-Growth Era, Screening For Growth Stocks by YCharts

eBay's 'Weak' Guidance Doesn't Change The Phenomenal Story by Valuentum

Bear Of The Day: Sherwin Williams by Zacks Investment Research

Bull Of The Day: Syntel by Zacks Investment Research

Cheap Stocks To Avoid: Round 1 by Stan Stafford

Detroit's Bankruptcy Might Be A Blessing In Disguise For Bond Insurers by George Kesarios

5 Significant Short Interest Increases by Bill Maurer

Apple Becoming A Good Speculation by Dana Blankenhorn

Cramer's Picks

Cramer's Mad Money - The Most Compelling IPO So Far This Year (7/30/13) by SA Editor Miriam Metzinger

Cramer's Lightning Round - Ascena Is A Lion's Den (7/30/13) by SA Editor Miriam Metzinger

Insider Ownership

Should You Join This Insider In Buying eBay? by Insider Monkey

IPO Analysis

Sprouts Farmers Market: Whole Food Market Is Available At Comparatively Better Valuations by Vivek Gupta


Why are you receiving this? You subscribed to Investing Ideas at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.

To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.

Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001

No hay comentarios:

Publicar un comentario